?
Harris Bernard A Jr
Director
Raytheon Technologies Corporation
US, Waltham [HQ]
CIK
1337906
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
16,726
Price per Share :
$88.78
Equivalence :
$1,484,934.28
Transaction History
-
S16,726 Shares After TransactionValue : $1,554,681.70Sold $185,900.00Transaction Date : 11/12/24
-
Footnotes
-
-
Footnotes:#1 The price reported ($92.95) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $92.87 to $93.01 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.#2 Includes 712 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 356 shares in each of January 1, 2025 and April 1, 2025, if he is a director of the Company on those dates.
-
A17,302 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/16/23
-
Footnotes
-
-
Footnotes:#1 The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2023, if he is a director of the Company on those dates.#2 Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1.
-
A18,726 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/20/24
-
Footnotes
-
-
Footnotes:#1 Includes 1,424 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 356 shares on July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025, if he is a director of the Company on those dates.